NCT04268836View on ClinicalTrials.gov

Vision Improvement for Patients With Age-Related Macular Degeneration

NAUnknownINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 9, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

May 1, 2025

Conditions
Age-related Macular Degeneration
Interventions
DEVICE

Optimal Acuity Clear-K® Low Vision Aid System treatment

The treatment involves irradiation of the cornea with low energy light in a treatment pattern that produces corneal shape change.

Trial Locations (1)

M4G 3E8

1929 Bayview Ave., Suite 117, Toronto

Sponsors
All Listed Sponsors
collaborator

Bochner Eye Institute

UNKNOWN

lead

Optimal Acuity Corporation

INDUSTRY

NCT04268836 - Vision Improvement for Patients With Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter